2-(Trifluoromethyl)thiazole-5-carbaldehyde, 95.0%, 1g

1,3-Dibromo-5-(methoxymethyl)benzene, 98%, 250mg

1-(((5-Nitrofuran-2-yl)methylene)amino)imidazolidine-2,4-dione, 95.0%, 10g

(2E)-3-(3-ethoxyphenyl)acrylic acid, 25g

6-Methylsulfanyl-pyridin-3-ylamine, 5g

Microliter syringe GASTIGHT® series 1000, 5.0 ml, 1005 TLL, 1 piece

[(2,6-dichlorophenyl)methyl](propyl)amine, 95.0%, 2g

2-([1,1'-Biphenyl]-4-ylcarbamoyl)benzoic acid, 95.0%, 1g

7-Boc-1-oxo-2,7-diazaspiro[3.5]nonane, 95.0%, 100mg

Methyl 5-methylthiophene-2-carboxylate, 95.0%, 1g

3-Bromo-5-(trifluoromethoxy)benzoyl chloride, 95.0%, 1g

7-Bromo-5-methylbenzo[e][1,2,4]triazin-3-amine, 98%, 5g

Ethyl 5-oxo-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-carboxylate, 95.0%, 5g